1-1 of 1
Lawrence Steinman, M.D.
Close
Sort by
Journal Articles

Type II HMG-CoA Reductase Inhibitors (Statins) Provide Acute-Graft-Versus-Host Disease Protection by Th-2 Cytokine Induction While Sparing Graft-Versus-Leukemia Activity.

Robert Zeiser, MD, Sawsan Youssef, Ph.D., Jeanette Baker, Lawrence Steinman, M.D., Robert Negrin, M.D.
Journal: Blood
Blood (2006) 108 (11): 189.
https://doi.org/10.1182/blood.V108.11.189.189
Published: 2006